资讯

Ophthalmology Times8 小时
A reviews of the TEASE-1 clinical trial with Benjamin Bakall, MD, PhD
The TEASE-1 trial reveals gildeuretinol's potential to reduce vision loss in Stargardt disease, offering hope for future ...
Ophthalmology Times12 小时
Q&A: The ELEVATUM Study with J. Fernando Arevalo
The ELEVATUM study explored faricimab's effectiveness in treating diabetic macular edema among underrepresented minorities, ...
Ophthalmology Times12 小时
FDA nod for acoltremon: What its approval means for clinicians and patients
On the heels of its FDA approval, clinicians weigh in on acoltremon’s (Tryptry) novel mechanism of action and its potential ...